Alphamab Oncology
9966.HK News Today: Stay Updated with the Latest Alphamab Oncology News in Real Time
Find 9966.HK news now at Meyka AI. Stay informed with the latest Alphamab Oncology stocks updates, including price news, market analysis, and expert insights.
Eli Lilly Retevmo Cuts Cancer Recurrence or Death Risk by 83% in Phase 3 Trial of 151 NSCLC Patients
On May 31, 2026, Eli Lilly (NYSE: LLY) delivered one of the most significant oncology data readouts of the year. The Phase 3 LIBRETTO-432 trial of Retevmo (selpercatinib) met its primary endpoint with results that are difficult to overstate. In 151 patients with early-stage RET fusion-positive non-small cell lung cancer (NSCLC), Retevmo reduced the risk…
IMMX Maintained at Buy by H.C. Wainwright, May 2026
H.C. Wainwright maintains Buy rating on IMMX, raises price target to $20 from $15 on May 22, 2026.
ViewRay Stock Surges 2400% on XETRA as MRI Cancer Therapy Demand Grows
6L9.F stock jumps 2400% to €0.025 on XETRA. ViewRay’s MRIdian radiation therapy system gains traction in healthcare sector.
Innate Pharma Stock Tumbles 16.3% as Biotech Faces Clinical Trial Headwinds
IPH.PA stock drops 16.3% to €1.64 on EURONEXT. Innate Pharma faces clinical trial delays and cash burn concerns in oncology pipeline.
GH Stock: Cowen Maintains Buy Rating on Guardant Health
Cowen & Co. maintains Buy rating on Guardant Health (GH) following G360 Liquid FDA approval, stock up 2.47%.
Sun Pharmaceutical (SUNPHARMA.NS) Earnings Preview: EPS at $11.34 Expected
SUNPHARMA.NS earnings preview: EPS estimate $11.34, revenue $145.57B. Analyst expectations ahead of May 22, 2026 report.
Solasia Pharma K.K. (4597.T) Jumps 4% on Intraday Strength
4597.T stock surges 4% intraday to ¥26.0 on trading volume. Solasia Pharma K.K. oncology pipeline faces headwinds.
LIMN Stock Surges 39% as Liminatus Pharma Gains Momentum
LIMN stock jumps 39% to $0.2647 on heavy trading volume. Liminatus Pharma biotech shares rally on intraday momentum.
TOI Insider Buying: Chernett Jorey Acquires 30K Shares May 21, 2026
Chernett Jorey, 10% owner of The Oncology Institute (TOI), purchased 30,000 shares at $4.09 on May 19, 2026. Insider buying signal.